Last reviewed · How we verify

NCT04627558

Validity Reliability of The Dubousset Functional Test in Stroke Patients

Completed Last updated 19 April 2022
What this trial tests

trial testing stroke patients, balance assessment in Stroke Syndrome in 61 participants. Completed in 15 February 2022.

Timeline
6 November 2020
Primary endpoint
1 February 2022
15 February 2022

Quick facts

Lead sponsorKırıkkale University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment61
Start date6 November 2020
Primary completion1 February 2022
Estimated completion15 February 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kırıkkale University

Who can join

Adults 18 to 85, any sex, with Stroke Syndrome or Balance; Distorted. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Increased muscle tone, decreased normal range of motion, and functional impairments may result in decreased load on the affected limb, deviations in gait patterns, balance and coordination disorders in individuals with stroke. In the literature, there are many scales that evaluate balance and functional performance in stroke. However there is no validity and reliability study of Dubousset Function Test developed to evaluate balance and functional performance of stroke. For this reason, the aim of study is to examine the validity and reliability of Dubousset Function Test in stroke patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Stroke Syndrome

Currently open trials in the same condition.

Other Kırıkkale University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04627558.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing